Logo image of LRHC

LA ROSA HOLDINGS CORP (LRHC) Stock Fundamental Analysis

NASDAQ:LRHC - Nasdaq - US50172T1034 - Common Stock - Currency: USD

0.1422  0 (-2.07%)

Premarket: 0.1427 +0 (+0.35%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LRHC. LRHC was compared to 65 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of LRHC have multiple concerns. LRHC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

LRHC had negative earnings in the past year.
LRHC had a negative operating cash flow in the past year.
LRHC Yearly Net Income VS EBIT VS OCF VS FCFLRHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -91.82%, LRHC is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -364.72%, LRHC is doing worse than 83.08% of the companies in the same industry.
Industry RankSector Rank
ROA -91.82%
ROE -364.72%
ROIC N/A
ROA(3y)-40.38%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LRHC Yearly ROA, ROE, ROICLRHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

LRHC has a worse Gross Margin (8.48%) than 69.23% of its industry peers.
In the last couple of years the Gross Margin of LRHC has declined.
The Profit Margin and Operating Margin are not available for LRHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.17%
GM growth 5YN/A
LRHC Yearly Profit, Operating, Gross MarginsLRHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 -20

1

2. Health

2.1 Basic Checks

LRHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
LRHC has more shares outstanding than it did 1 year ago.
LRHC has a better debt/assets ratio than last year.
LRHC Yearly Shares OutstandingLRHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
LRHC Yearly Total Debt VS Total AssetsLRHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M

2.2 Solvency

LRHC has an Altman-Z score of -0.54. This is a bad value and indicates that LRHC is not financially healthy and even has some risk of bankruptcy.
LRHC has a Altman-Z score of -0.54. This is in the lower half of the industry: LRHC underperforms 73.85% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that LRHC is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, LRHC is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z -0.54
ROIC/WACCN/A
WACC9.34%
LRHC Yearly LT Debt VS Equity VS FCFLRHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 0.76 indicates that LRHC may have some problems paying its short term obligations.
LRHC has a Current ratio of 0.76. This is in the lower half of the industry: LRHC underperforms 73.85% of its industry peers.
A Quick Ratio of 0.76 indicates that LRHC may have some problems paying its short term obligations.
LRHC has a worse Quick ratio (0.76) than 67.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
LRHC Yearly Current Assets VS Current LiabilitesLRHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M

3

3. Growth

3.1 Past

The earnings per share for LRHC have decreased strongly by -471.38% in the last year.
Looking at the last year, LRHC shows a very strong growth in Revenue. The Revenue has grown by 139.99%.
LRHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.59% yearly.
EPS 1Y (TTM)-471.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-270.68%
Revenue 1Y (TTM)139.99%
Revenue growth 3Y9.59%
Revenue growth 5YN/A
Sales Q2Q%188.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LRHC Yearly Revenue VS EstimatesLRHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LRHC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LRHC Price Earnings VS Forward Price EarningsLRHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LRHC Per share dataLRHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LRHC!.
Industry RankSector Rank
Dividend Yield N/A

LA ROSA HOLDINGS CORP

NASDAQ:LRHC (5/20/2025, 8:12:48 PM)

Premarket: 0.1427 +0 (+0.35%)

0.1422

0 (-2.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.68%
Inst Owner Change90.04%
Ins Owners33.48%
Ins Owner Change66.47%
Market Cap5.79M
AnalystsN/A
Price TargetN/A
Short Float %0.42%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.55
BVpS0.12
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -91.82%
ROE -364.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.48%
FCFM N/A
ROA(3y)-40.38%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.17%
GM growth 5YN/A
F-Score4
Asset Turnover3.21
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z -0.54
F-Score4
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-471.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-270.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)139.99%
Revenue growth 3Y9.59%
Revenue growth 5YN/A
Sales Q2Q%188.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-665.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-143.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.91%
OCF growth 3YN/A
OCF growth 5YN/A